No. Just like the FDA meeting wasn't a deal catalyst, nor the FDA minutes, nor the EMA meeting. There's no catalyst that we are "just waiting for", as much as you want to believe that and keep coming up with new ones, one after the other. The only catalyst is a partner saying they want to license. And this is what management is trying to do.
In the meantime, management is moving forward doing things they can with limited capital. Hats off to them for that. They are not giving up.
(The catalyst for our previous term sheet was quite clearly the BTD, which would have been very meaningful and valuable to a partner. The pharma was obviously not sure it would be granted, nor our management for that matter though they had to try; you'll note they heavily backed off on touting possible BTD after final B-OM results were in, only saying they would apply in the 10Q's.)
News 
Market Data 
Discover 
